₹341.35-4.00 (-1.16%)
21-Mar-2025₹340.10-4.50 (-1.31%)
21-Mar-2025BSE : 509079
NSE : GUFICBIO
Sector : Health care
ISIN Code : INE742B01025
Last Updated: 21-Mar-2025
Market Cap (₹ Cr) | 3,424 |
Traded Value (₹ Cr) | 0.25 |
Volume (Shares) | 7,466 |
Face Value (₹) | 1 |
52-Week High (₹) | 501.10 |
52-Week High Date | 08-Nov-2024 |
52-Week Low (₹) | 278.00 |
52-Week Low Date | 04-Jun-2024 |
All Time High (₹) | 501.10 |
All Time High Date | 08-Nov-2024 |
All Time Low (₹) | 0.17 |
All Time Low Date | 18-Mar-1992 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 3,411 |
EPS - TTM (₹) [C] | 8.17 |
P/E Ratio (X) [C] | 41.63 |
Face Value (₹) | 1 |
Latest Dividend (%) | 10.00 |
Latest Dividend Date | 17-Sep-2024 |
Dividend Yield (%) | 0.03 |
Book Value Share (₹) [C] | 57.26 |
P/B Ratio (₹) [C] | 5.94 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Motilal Oswal Small Cap Fund - Direct (IDCW) | 44.95 | 13,59,955 | 1.21 |
Motilal Oswal Small Cap Fund - Direct (G) | 44.95 | 13,59,955 | 1.21 |
Motilal Oswal Small Cap Fund - Regular (IDCW) | 44.95 | 13,59,955 | 1.21 |
Motilal Oswal Small Cap Fund - Regular (G) | 44.95 | 13,59,955 | 1.21 |
SBI Healthcare Opportunities Fund - Direct (IDCW) | 33.06 | 10,00,000 | 1.00 |
SBI Healthcare Opportunities Fund - Direct (G) | 33.06 | 10,00,000 | 1.00 |
SBI Healthcare Opportunities Fund (G) | 33.06 | 10,00,000 | 1.00 |
SBI Healthcare Opportunities Fund (IDCW) | 33.06 | 10,00,000 | 1.00 |
ICICI Pru Smallcap Fund - Direct (G) | 15.05 | 4,55,351 | 0.22 |
ICICI Pru Smallcap Fund (IDCW) | 15.05 | 4,55,351 | 0.22 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 337.00 347.50 |
Week Low/High (₹) | 315.55 350.00 |
Month Low/High (₹) | 310.00 393.00 |
Year Low/High (₹) | 278.00 504.00 |
All time Low/High (₹) | 0.17 504.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 3.94% | -97.90% | 4.17% | 4.26% |
1 Month | -11.33% | -98.22% | 2.12% | 2.43% |
3 Month | -21.19% | -98.42% | -1.46% | -1.01% |
6 Month | -16.16% | -98.31% | -9.04% | -9.46% |
1 Year | 15.37% | -97.66% | 5.87% | 6.08% |
3 Year | 41.00% | -97.16% | 34.23% | 36.41% |
Chairman & Managing Director : Jayesh P Choksi
Whole Time Director & CEO : Pranav J Choksi
Whole-time Director : Pankaj Gandhi
Company Sec. & Compli. Officer : Ami Naresh Shah
Non-Exec. & Independent Dir. : Shrirang V Vadiya
Non-Exec & Non-Independent Dir : Balram Singh
Non-Exec. & Independent Dir. : Rabi Narayan Sahoo
Non-Exec. & Independent Dir. : Anusanjiv Aurora
Whole-time Director : Dilip Ghosh
Non-Exec. & Independent Dir. : Kamal Kishore Seth
Additional Director : Akshya Kumar Mahapatra
Registered Office: Shop-37 1st Flr Kamala Bhavan, Swami Nityanand Road Andheri(E,Mumbai,Maharashtra-400069 Ph: 91-022-66919187/67261007/66919189
1. What's the Gufic BioSciences Ltd share price today?
Gufic BioSciences Ltd share price was Rs 341.35 at close on 21st Mar 2025. Gufic BioSciences Ltd share price was down by 1.16% from the previous closing price of Rs 345.35. Gufic BioSciences Ltd share price trend:
2. How can I quickly analyse the performance of the Gufic BioSciences Ltd stock?
The performance of the Gufic BioSciences Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Gufic BioSciences Ltd?
Gufic BioSciences Ltd has a market capitalisation of Rs 3,424 crore.
4. What is Gufic BioSciences Ltd's 52-week high/low share price?
The Gufic BioSciences Ltd’s 52-week high share price is Rs 501.10 and 52-week low share price is Rs 278.00.
5. Is the Gufic BioSciences Ltd profitable?
On a consolidated basis, Gufic BioSciences Ltd reported a profit of Rs 19.32 crore on a total income of Rs 209.65 crore for the quarter ended 2024. For the year ended Dec 2024, Gufic BioSciences Ltd had posted a profit of Rs 19.31 crore on a total income of Rs 209.66 crore.
6. Which are Gufic BioSciences Ltd’s peers in the Health care sector?
Gufic BioSciences Ltd’s top 5 peers in the Health care sector are RPG LifeScience., Sequent Scien., Dishman Carbogen, Gufic BioScience, Aarti Drugs, Advanced Enzyme, Senores Pharma..
7. Who owns how much in Gufic BioSciences Ltd?
Key changes to the Gufic BioSciences Ltd shareholding are as follows: